Letters to the Editor
NAFLD in Children and Adolescents
Am Fam Physician. 2021 Apr 15;103(8):452-453.
Original Article: Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management
Issue Date: November 15, 2020
See additional reader comments at: https://www.aafp.org/afp/2020/1115/p603.html
To the Editor: We thank Dr. Westfall and colleagues for their comprehensive article about nonalcoholic fatty liver disease (NAFLD). The article focused on adults and did not discuss the prevalence of NAFLD in children and adolescents. A retrospective review of liver histology in 742 child autopsies performed from 1993 to 2003 identified an adjusted NAFLD prevalence of 9.6% in two- to 19-year-olds that was standardized for age, gender, race, and ethnicity, and the study found a prevalence ranging from 0.7% in toddlers and preschoolers to 38% in children who were obese.1 In a more recent study of unexpected childhood deaths in New York City, NAFLD was found histologically in 4.5% of children.2
Obesity, race, and metabolic and genetic factors with comorbidities are associated with NAFLD in children younger than 18 years. Although the literature considers risk factors, biomarkers, and imaging tools to be helpful for diagnosis, opinions differ about the use of invasive diagnostic procedures. A liver biopsy provides a definite diagnosis and allows for the assessment of disease severity; however, concerns about the risks of liver biopsies in adults also apply to children.3
The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) issued a clinical practice guideline for the diagnostic evaluation of suspected NAFLD.4 The American Academy of Pediatrics (AAP) endorsed the guideline and key recommendations5:
Screen children nine to 11 years of age who have risk factors such as obesity using an alanine transaminase test.
Rule out other medical conditions (e.g., Wilson's disease, hepatitis C) using additional tests.
Consider liver biopsy to detect the presence of fat deposits.
Recommend diet modifications (e.g., reduction of sugar-sweetened beverages) and increased physical activity.
The NASPGHAN and AAP guidelines, pediatric gastroenterologists, and referral centers for patients with NAFLD are valuable resources that can assist family physicians in the diagnosis and management of this complex disease in children.
Author disclosure: No relevant financial affiliations.
Referencesshow all references
1. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388–1393....
2. Fernandes DM, Pantangi V, Azam M, et al. Pediatric non-alcoholic fatty liver disease in New York City: an autopsy study. J Pediatr. 2018;200:174–180.
3. Schwimmer JB. Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2016;63(5):1718–1725.
4. Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of non-alcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr. 2017;64(2):319–334.
5. Jenco M. AAP endorses new guidelines on non-alcoholic fatty liver disease. AAP News. December 2, 2016. Accessed December 8, 2020. https://www.aappublications.org/news/2016/12/02/FattyLiver120216#main-content
In Reply: Thank you for raising awareness of NAFLD in children and adolescents. NAFLD in this population was considered outside the scope of our article; however, this topic warrants family physicians' attention. Your letter describes the prevalence of and risk factors for NAFLD in children and provides current expert consensus recommendations. Adults with the onset of NAFLD in childhood may be most at risk of complications; therefore, primary care clinicians should identify these patients to allow for early intervention.1
The American Association for the Study of Liver Diseases does not recommend screening for NAFLD in children who are overweight or obese; however, they acknowledge the risk of NAFLD in children with metabolic syndrome, diabetes mellitus, and excess weight.1 Several national organizations provide guidance for the evaluation of suspected NAFLD in children, including the NASPGHAN and AAP. The National Institute for Health and Care Excellence guidelines are based on expert opinion and recommend that clinicians offer liver ultrasonography to children and adolescents with type 2 diabetes who do not use alcohol.2 If the results are normal, ultrasonography should be repeated every three years.1,2
Interventions for NAFLD affecting both children and adults include intensive lifestyle modifications. Family physicians can apply their expertise in treating the whole patient (and family) in a compassionate, contextual, and comprehensive way to engage patients in behavior changes.
Author disclosure: No relevant financial affiliations.
1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease. Hepatology. 2018;67(1):328–357.
2. Glen J, Floros L, Day C, et al.; Guideline Development Group. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance. BMJ. 2016;354:i4428.
Send letters to email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680. Include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the AAFP permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.
Copyright © 2021 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions